Pediatrix Medical Group Inc (NYSE: MD) kicked off on Tuesday, up 4.10% from the previous trading day, before settling in for the closing price of $9.03. Over the past 52 weeks, MD has traded in a range of $7.70-$15.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -7.30%. While this was happening, its average annual earnings per share was recorded -1.27%. With a float of $83.13 million, this company’s outstanding shares have now reached $84.12 million.
Pediatrix Medical Group Inc (MD) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of Pediatrix Medical Group Inc is 1.18%, while institutional ownership is 98.32%. The most recent insider transaction that took place on Dec 14 ’23, was worth 55,219. In this transaction Chief Executive Officer of this company sold 5,764 shares at a rate of $9.58, taking the stock ownership to the 90,874 shares. Before that another transaction happened on Dec 14 ’23, when Company’s EVP, General Counsel & Sec sold 1,150 for $9.62, making the entire transaction worth $11,063. This insider now owns 15,730 shares in total.
Pediatrix Medical Group Inc (MD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -1.27% per share during the next fiscal year.
Pediatrix Medical Group Inc (NYSE: MD) Trading Performance Indicators
Take a look at Pediatrix Medical Group Inc’s (MD) current performance indicators. Last quarter, stock had a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.40. Likewise, its price to free cash flow for the trailing twelve months is 5.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit 0.19 in the next quarter and is forecasted to reach 1.29 in one year’s time.
Technical Analysis of Pediatrix Medical Group Inc (MD)
The latest stats from [Pediatrix Medical Group Inc, MD] show that its last 5-days average volume of 0.52 million was inferior to 0.7 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 44.68%. Additionally, its Average True Range was 0.31.
During the past 100 days, Pediatrix Medical Group Inc’s (MD) raw stochastic average was set at 68.55%, which indicates a significant decrease from 71.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.13% in the past 14 days, which was lower than the 38.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.19, while its 200-day Moving Average is $10.94. Now, the first resistance to watch is $9.63. This is followed by the second major resistance level at $9.87. The third major resistance level sits at $10.21. If the price goes on to break the first support level at $9.05, it is likely to go to the next support level at $8.71. The third support level lies at $8.47 if the price breaches the second support level.
Pediatrix Medical Group Inc (NYSE: MD) Key Stats
The company with the Market Capitalisation of 790.73 million has total of 84,026K Shares Outstanding. Its annual sales at the moment are 1,995 M in contrast with the sum of -60,410 K annual income. Company’s last quarter sales were recorded 496,440 K and last quarter income was -124,290 K.
